M11.27
Other chondrocalcinosis, ankle and foot
Clinical Classification Guidelines
Medical Intelligence & Overview
Other chondrocalcinosis, classified under ICD-10 code M11.27, refers to a form of calcium crystal deposition in the cartilage of the ankle and foot joints. This condition involves the accumulation of calcium pyrophosphate dihydrate (CPPD) crystals, which can cause joint inflammation, pain, and deterioration. Unlike more common joint diseases such as osteoarthritis or gout, chondrocalcinosis specifically targets cartilage, leading to characteristic calcifications visible on imaging studies. Recognizing this condition is essential for appropriate management and symptom relief.
Causes & Symptoms
Clinical Causes: Age-related cartilage degeneration Genetic predisposition to crystal deposition Joint trauma or injury Metabolic disorders such as hyperparathyroidism, hemochromatosis, or hypophosphatasia Chronic kidney disease affecting mineral metabolism Other underlying joint diseases or infections
Key Symptoms: Joint pain, often intermittent and throbbing Swelling and inflammation in affected joints Stiffness, especially after periods of inactivity Reduced joint mobility or range of motion Tenderness upon touching the joint Possible warmth over the joint area
Diagnostic & Treatment
Diagnosis Path: The diagnosis of other chondrocalcinosis involves a combination of clinical evaluation and imaging techniques. Key steps include: - Medical history review focusing on joint symptoms and potential risk factors - Physical examination to assess swelling, tenderness, and range of motion - Imaging studies, primarily X-rays, revealing characteristic calcifications in the cartilage of ankle and foot joints - Arthrocentesis (joint fluid aspiration) to identify CPPD crystals under polarized light microscopy - Blood tests to evaluate metabolic factors that may contribute to calcium crystal deposition While imaging is essential for visual confirmation, microscopic analysis provides definitive evidence of crystal presence.
Treatment Protocols: Management strategies aim to alleviate symptoms and prevent joint deterioration. Typical approaches include: - Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation - Colchicine to reduce crystal formation and flare-ups - Corticosteroid injections directly into the affected joint for severe inflammation - Lifestyle modifications such as weight management and joint protection - Addressing underlying metabolic disorders through specialized treatment - Physical therapy to improve joint function and flexibility In some cases, surgical intervention may be necessary for joint repair or replacement if degeneration becomes significant. Regular monitoring and follow-up consultations are vital for ongoing management of the condition.
Clinical Advice & FAQs
Billing Guidance
Is M11.27 a billable ICD-10 code?
Yes, M11.27 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.27?
Clinical documentation must specify the nature of Other chondrocalcinosis, ankle and foot and any associated comorbidities for accurate reporting.
Cite this Clinical Reference